Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer
Kyung‐min Lee(Hanyang University), Carlos L. Arteaga(The University of Texas Southwestern Medical Center)
Cited by 52
Related Papers
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
|Breast Cancer Research|2011|463
Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors
|Cancer Research|2006|79
Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells
|Breast Cancer Research|2014|77